Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.
- Revenue: $176.24M. Running result $176.24M. Bile Acid Medicines: $47.52M. Livmarli: $128.72M.
- Cost of revenue: $0. Running result $176.24M.
- Gross profit: $176.24M. Running result $176.24M.
- Operating costs: −$218.78M. Running result −$42.54M.
- Operating income: −$42.54M. Running result −$42.54M.
- Other expense: −$23M. Running result −$65.54M.
- Pre-tax loss: −$65.54M. Running result −$65.54M.
- Income tax expense: −$1.69M. Running result −$67.23M.
- Net loss: −$67.23M. Running result −$67.23M.
